A fragment-based approach for the discovery of isoform-specific p38α inhibitors

被引:42
作者
Chen, Jinhua
Zhang, Ziming
Stebbins, John L.
Zhang, Xiyun
Hoffman, Randy
Moore, Ambika
Pellecchia, Maurizio
机构
[1] Burnham Inst Med Res, La Jolla, CA 92037 USA
[2] Invitrogen Corp, Introvegen Discovery Sci, Madison, WI 53719 USA
关键词
D O I
10.1021/cb700025j
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this study, we describe a novel approach for lead discovery against protein kinases, pharmacophore by interligand nuclear Overhauser effect (ILOE), in which a pair of ligands that bind to adjacent pockets on the target surface is identified by the detection of protein-mediated ILOEs. We demonstrate that a pharmacophore-based search guided by experimental binding data of weakly interacting fragments can be rapidly and efficiently used to identify (or synthesize) high-affinity, selective ligands. Targeting the inactive state of protein kinases represents a promising approach to achieve selectivity and cellular efficacy. In this respect, when we apply the method for the discovery of potent p38 inhibitors, we also demonstrate that the resulting bidentate compounds are highly selective and exhibit a cellular activity that parallels their in vitro binding to the inactive form of the kinase. The method is relatively simple and of general applicability, and as such we anticipate its potential implementation against a variety of macromolecular targets, including not only protein kinases but also those involved in proteinprotein interactions or even nucleic acids.
引用
收藏
页码:329 / 336
页数:8
相关论文
共 30 条
[1]   SAR by ILOEs: An NMIR-based approach to reverse chemical genetics [J].
Becattini, B ;
Pellecchia, M .
CHEMISTRY-A EUROPEAN JOURNAL, 2006, 12 (10) :2658-2662
[2]   Targeting apoptosis via chemical design: Inhibition of bid-induced cell death by small organic molecules [J].
Becattini, B ;
Sareth, S ;
Zhai, DY ;
Crowell, KJ ;
Leone, M ;
Reed, JC ;
Pellecchia, M .
CHEMISTRY & BIOLOGY, 2004, 11 (08) :1107-1117
[3]   Structure-activity relationships by interligand NOE-based design and synthesis of antiapoptotic compounds targeting Bid [J].
Becattini, Barbara ;
Culmsee, Carsten ;
Leone, Marilisa ;
Zhai, Dayong ;
Zhang, Xiyun ;
Crowell, Kevin J. ;
Rega, Michele F. ;
Landshamer, Stefan ;
Reed, John C. ;
Plesnila, Nikolaus ;
Pellecchia, Maurizio .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (33) :12602-12606
[4]   A rule of three for fragment-based lead discovery? [J].
Congreve, M ;
Carr, R ;
Murray, C ;
Jhoti, H .
DRUG DISCOVERY TODAY, 2003, 8 (19) :876-877
[5]   Comparison of automated docking programs as virtual screening tools [J].
Cummings, MD ;
DesJarlais, RL ;
Gibbs, AC ;
Mohan, V ;
Jaeger, EP .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (04) :962-976
[6]   Fragment-based drug discovery [J].
Erlanson, DA ;
McDowell, RS ;
O'Brien, T .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (14) :3463-3482
[7]   The SHAPES strategy: an NMR-based approach for lead generation in drug discovery [J].
Fejzo, J ;
Lepre, CA ;
Peng, JW ;
Bemis, GW ;
Ajay ;
Murcko, MA ;
Moore, JM .
CHEMISTRY & BIOLOGY, 1999, 6 (10) :755-769
[8]   High-throughput assays for promiscuous inhibitors [J].
Feng, BY ;
Shelat, A ;
Doman, TN ;
Guy, RK ;
Shoichet, BK .
NATURE CHEMICAL BIOLOGY, 2005, 1 (03) :146-148
[9]   Molecular complexity and its impact on the probability of finding leads for drug discovery [J].
Hann, MM ;
Leach, AR ;
Harper, G .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2001, 41 (03) :856-864
[10]   Fragment-based lead discovery using X-ray crystallography [J].
Hartshorn, MJ ;
Murray, CW ;
Cleasby, A ;
Frederickson, M ;
Tickle, IJ ;
Jhoti, H .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (02) :403-413